Smith & Nephew SNATS (SNN)
(Delayed Data from NYSE)
$28.52 USD
+0.17 (0.60%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $28.51 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SNN 28.52 +0.17(0.60%)
Will SNN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNN
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
SNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Smith & Nephew's (SNN) CORIOGRAPH to Aid Arthroplasty Procedure
Smith+Nephew (SNN) Expands in Australia With New Alliance
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
Other News for SNN
LONDON BROKER RATINGS: Deutsche Bank starts Smith & Nephew at 'buy'
LONDON BRIEFING: Reckitt to simplify; Informa agrees Ascential buy
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEMâ„¢ Primary Hip System
Smith & Nephew announces 510(k) clearance for CATALYSTEM Primary Hip System
Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board